Ray Dalio's position in Neurocrine Biosciences is currently worth $38.5 Million. That's 0.18% of their equity portfolio (100th largest holding). The first Neurocrine Biosciences trade was made in Q2 2021. Since then Ray Dalio bought shares six more times and sold shares on seven occasions. The investor's estimated purchase price is $41.5 Million, resulting in a loss of 7.3%.